Kjell Magne Tveit

Image of Kjell Magne Tveit
Norwegian version of this page
Username
Visiting address Forskningsveien 2 A OUS Rikshospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo
Tags: Nordic

Publications

  • Smedman, Tor Magnus; Guren, Tormod Kyrre; Tveit, Magne Kjell; Thomsen, Maria; Andersen, Marit Helen & Line, Pål Dag [Show all 7 contributors for this article] (2022). Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy. Transplant International. ISSN 0934-0874. 35. doi: 10.3389/ti.2022.10404. Full text in Research Archive
  • Adams, Richard A; Goey, Kaitlyn K.H.; Chibaudel, Benoist; Koopman, Miriam; Punt, Cornelis & Arnold, Dirk [Show all 17 contributors for this article] (2021). Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis. Cancer Treatment Reviews. ISSN 0305-7372. 99. doi: 10.1016/j.ctrv.2021.102226.
  • Hamfjord, Julian; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan; Pfeiffer, Per & Dajani, Olav [Show all 11 contributors for this article] (2021). Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer. International Journal of Cancer. ISSN 0020-7136. 149(6), p. 1385–1397. doi: 10.1002/ijc.33672. Full text in Research Archive
  • Hamfjord, Julian; Myklebust, Tor Åge; Larsen, Inger Kristin; Kure, Elin Wenche Hegland; Glimelius, Bengt & Guren, Tormod Kyrre [Show all 8 contributors for this article] (2021). Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 31(2), p. 342–351. doi: 10.1158/1055-9965.EPI-21-0555. Full text in Research Archive
  • Olsen, Frank; Jacobsen, Bjarne K.; Heuch, Ivar; Tveit, Magne Kjell & Balteskard, Lise (2021). Equitable access to cancer patient pathways in Norway – a national registry-based study. BMC Health Services Research. ISSN 1472-6963. 21(1), p. 1–13. doi: 10.1186/s12913-021-07250-1. Full text in Research Archive
  • Hamfjord, Julian; Guren, Tormod Kyrre; Dajani, Olav; Johansen, Julia Sidenius; Glimelius, Bengt & Sorbye, Halfdan [Show all 12 contributors for this article] (2019). Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy. Annals of Oncology. ISSN 0923-7534. 30(7), p. 1088–1095. doi: 10.1093/annonc/mdz139. Full text in Research Archive
  • Thomsen, Maria; Skovlund, Eva; Sorbye, Halfdan; Bolstad, Nils; Nustad, Kjell Johannes & Glimelius, Bengt [Show all 12 contributors for this article] (2018). Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome. British Journal of Cancer. ISSN 0007-0920. 118(12), p. 1609–1616. doi: 10.1038/s41416-018-0115-9. Full text in Research Archive
  • Holme, Øyvind; Løberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernán, Miguel A. & Aas, Eline [Show all 14 contributors for this article] (2018). Long-term effectiveness of sigmoidoscopy screening on colorectal cancer incidence and mortality in women and men: A randomized trial. Annals of Internal Medicine. ISSN 0003-4819. 168(11), p. 775–782. doi: 10.7326/M17-1441. Full text in Research Archive
  • Guren, Tormod Kyrre; Thomsen, Maria; Kure, Elin H.; Sorbye, Halfdan; Glimelius, Bengt & Pfeiffer, Per [Show all 12 contributors for this article] (2017). Cetuximab in treatment of metastatic colorectal cancer: Final survival analyses and extended RAS data from the NORDIC-VII study. British Journal of Cancer. ISSN 0007-0920. 116(10), p. 1271–1278. doi: 10.1038/bjc.2017.93.
  • Thomsen, Maria; Guren, Marianne; Skovlund, Eva; Glimelius, Bengt; Hjermstad, Marianne Jensen & Johansen, Julia S. [Show all 12 contributors for this article] (2017). Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status. European Journal of Cancer. ISSN 0959-8049. 81, p. 26–35. doi: 10.1016/j.ejca.2017.04.026.
  • Thomsen, Maria; Kersten, Christian; Sorbye, Halfdan; Skovlund, Eva; Glimelius, Bengt & Pfeiffer, Per [Show all 12 contributors for this article] (2016). Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. OncoTarget. ISSN 1949-2553. 7(46), p. 75013–75022. doi: 10.18632/oncotarget.12601.
  • Mezheyeuski, Artur; Lindh, Maja Bradic; Guren, Tormod Kyrre; Dragomir, Anca; Pfeiffer, Per & Kure, Elin H. [Show all 19 contributors for this article] (2016). Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. OncoTarget. ISSN 1949-2553. 7(27), p. 41948–41958. doi: 10.18632/oncotarget.9632. Full text in Research Archive
  • Tarpgaard, Line Schmidt; Ørum-Madsen, Maj Sofie; Christensen, Ib Jarle; Nordgaard, Cathrine; Noer, Julie & Guren, Tormod Kyrre [Show all 15 contributors for this article] (2016). TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer. OncoTarget. ISSN 1949-2553. 7(37), p. 59441–59457. doi: 10.18632/oncotarget.11118.
  • Kjersem, Janne Beathe; Thomsen, Maria; Guren, Tormod Kyrre; Hamfjord, Julian; Carlsson, G & Gustavsson, B. [Show all 13 contributors for this article] (2016). AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. The Pharmacogenomics Journal. ISSN 1470-269X. 16(3), p. 272–279. doi: 10.1038/tpj.2015.54.
  • Dueland, Svein; Guren, Tormod Kyrre; Hagness, Morten; Glimelius, Bengt; Line, Pål Dag & Pfeiffer, Per [Show all 8 contributors for this article] (2015). Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer? Annals of Surgery. ISSN 0003-4932. 261(5), p. 956–960. doi: 10.1097/SLA.0000000000000786.
  • Tarpgaard, Line Schmidt; Christensen, Ib J.; Høyer-Hansen, Gunilla; Lund, Ida K.; Guren, Tormod Kyrre & Glimelius, Bengt [Show all 12 contributors for this article] (2015). Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab. International Journal of Cancer. ISSN 0020-7136. 137(10), p. 2470–2477. doi: 10.1002/ijc.29476.
  • Gustavsson, Bengt; Carlsson, Göran; Machover, David; Petrelli, Nicholas; Roth, Arnaud & Schmoll, Hans-Joachim [Show all 8 contributors for this article] (2015). A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clinical colorectal cancer. ISSN 1533-0028. 14(1), p. 1–10. doi: 10.1016/j.clcc.2014.11.002.
  • Leon, Otilia; Guren, Marianne; Hagberg, Oskar; Glimelius, Bengt; Dahl, Olav & Havsteen, Hanne [Show all 17 contributors for this article] (2014). Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiotherapy and Oncology. ISSN 0167-8140. 113(3), p. 352–358. doi: 10.1016/j.radonc.2014.10.002.
  • Guren, Marianne; Undseth, Christine; Rekstad, Bernt Louni; Brandengen, Morten; Dueland, Svein & Spindler, Karen-Lise Garm [Show all 8 contributors for this article] (2014). Reirradiation of locally recurrent rectal cancer: A systematic review. Radiotherapy and Oncology. ISSN 0167-8140. 113(2), p. 151–157. doi: 10.1016/j.radonc.2014.11.021.
  • Åsli, Linn Merete; Kvaløy, Stein Olav; Jetne, Vidar; Myklebust, Tor Åge; Levernes, Sverre G. & Tveit, Magne Kjell [Show all 8 contributors for this article] (2014). Utilization of radiation therapy in norway after the implementation of the national cancer plan - A national, population-based study. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 90(3), p. 707–714. doi: 10.1016/j.ijrobp.2014.06.059.
  • Dueland, Svein; Hagness, Morten; Line, Pål Dag; Guren, Tormod Kyrre; Tveit, Magne Kjell & Foss, Aksel (2014). Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy? Annals of Surgical Oncology. ISSN 1068-9265. doi: 10.1245/s10434-014-4137-0.
  • Wiig, Johan N.; Giercksky, Karl-Erik & Tveit, Magne Kjell (2014). Intraoperative radiotherapy for locally advanced or locally recurrent rectal cancer: Does it work at all? Acta Oncologica. ISSN 0284-186X. 53(7), p. 865–876. doi: 10.3109/0284186X.2014.895037.
  • Tarpgaard, Line Schmidt; Guren, Tormod Kyrre; Glimelius, Bengt; Christensen, Ib J.; Pfeiffer, Per & Kure, Elin H. [Show all 11 contributors for this article] (2014). Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: Results from the NORDIC VII Study. PLOS ONE. ISSN 1932-6203. 9(2:e87746). doi: 10.1371/journal.pone.0087746.
  • Kjersem, Janne Beathe; Skovlund, Eva; Ikdahl, Tone; Guren, Tormod Kyrre; Kersten, Christian & Dalsgaard, Astrid Marie [Show all 10 contributors for this article] (2014). FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab. BMC Cancer. ISSN 1471-2407. 14. doi: 10.1186/1471-2407-14-340. Full text in Research Archive
  • Kjersem, Janne Beathe; Ikdahl, Tone; Lingjærde, Ole Christian; Guren, Tormod Kyrre; Tveit, Magne Kjell & Kure, Elin H. (2014). Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment. Molecular Oncology. ISSN 1574-7891. 8(1), p. 59–67. doi: 10.1016/j.molonc.2013.09.001.
  • Hauglann, Beate Kristin; Saltyte Benth, Jurate; Fosså, Sophie Dorothea; Tveit, Magne Kjell & Dahl, Alv A (2014). A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors. Acta Oncologica. ISSN 0284-186X. 53(6), p. 735–743. doi: 10.3109/0284186X.2013.844354.
  • Hauglann, Beate Kristin; Saltyte Benth, Jurate; Fosså, Sophie Dorothea; Tveit, Magne Kjell & Dahl, Alv A (2014). A controlled cohort study of long-term income in colorectal cancer patients. Supportive Care in Cancer. ISSN 0941-4355. doi: 10.1007/s00520-014-2258-4.
  • Holme, Øyvind; Løberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A. & Aas, Eline [Show all 11 contributors for this article] (2014). Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality A Randomized Clinical Trial. Journal of the American Medical Association (JAMA). ISSN 0098-7484. 312(6), p. 606–615. doi: 10.1001/jama.2014.8266.
  • Sveen, Anita; Nesbakken, Arild; Ågesen, Trude Holmeide; Guren, Marianne; Tveit, Magne Kjell & Skotheim, Rolf Inge [Show all 7 contributors for this article] (2013). Anticipating the Clinical Use of Prognostic Gene Expression-Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving? Clinical Cancer Research. ISSN 1078-0432. 19(24), p. 6669–6677. doi: 10.1158/1078-0432.CCR-13-1769.
  • Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H.; Rui, Hallgeir; Knudsen, Erik S. & Elsaleh, Hany [Show all 13 contributors for this article] (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer. ISSN 0007-0920. 107(10), p. 1684–1691. doi: 10.1038/bjc.2012.463.
  • Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, Per; Sorbye, Halfdan & Pyrhonen, Seppo [Show all 22 contributors for this article] (2012). Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. Journal of Clinical Oncology. ISSN 0732-183X. 30(15), p. 1755–1762. doi: 10.1200/JCO.2011.38.0915.
  • Bentzen, Anne Gry; Guren, Marianne; Wanderås, Eva Hoff; Frykholm, Gunilla; Tveit, Magne Kjell & Wilsgaard, Tom [Show all 8 contributors for this article] (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 83(2), p. E173–E180. doi: 10.1016/j.ijrobp.2011.12.062.
  • Hamfjord, Julian; Stangeland, Astrid Marie; Hughes, Timothy; Skrede, Martina; Tveit, Magne Kjell & Andersen, Tone Ikdahl [Show all 7 contributors for this article] (2012). Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing. PLOS ONE. ISSN 1932-6203. 7(4). doi: 10.1371/journal.pone.0034150.
  • Brændengen, Morten; Tveit, Magne Kjell; Hjermstad, Marianne Jensen; Johansson, Hemming; Berglund, Åke & Brandberg, Yvonne [Show all 7 contributors for this article] (2012). Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study. European Journal of Cancer. ISSN 0959-8049. 48(6), p. 813–819. doi: 10.1016/j.ejca.2011.06.035.
  • Kjersem, Janne Beathe; Andersen, Tone Ikdahl; Guren, Tormod Kyrre; Skovlund, Eva; Sorbye, Halfdan & Hamfjord, Julian [Show all 12 contributors for this article] (2012). Let-7 miRNA-binding site polymorphism in the KRAS 3 ' UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. BMC Cancer. ISSN 1471-2407. 12. doi: 10.1186/1471-2407-12-534.
  • Brændengen, Morten; Tveit, Magne Kjell; Bruheim, Kjersti; Småstuen, Milada C; Berglund, Åke & Glimelius, Bengt (2011). Late Patient-Reported Toxicity After Preoperative Radiotherapy or Chemoradiotherapy in Nonresectable Rectal Cancer: Results From a Randomized Phase III Study. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 81(4), p. 1017–1024. doi: 10.1016/j.ijrobp.2010.07.007.
  • Hamfjord, Julian; Stangeland, Astrid Marie; Skrede, Martina; Tveit, Magne Kjell; Andersen, Tone Ikdahl & Kure, Elin H. (2011). Wobble-enhanced ARMS Method for Detection of KRAS and BRAF Mutations. Diagnostic molecular pathology (Print). ISSN 1052-9551. 20(3), p. 158–165. doi: 10.1097/PDM.0b013e31820b49e2.
  • Bornholdt, Jette; Friis, Stine; Godiksen, Sine; Poulsen, Steen S.; Santoni-Rugiu, Eric & Bisgaard, Hanne C. [Show all 12 contributors for this article] (2011). The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer. ISSN 1471-2407. 11. doi: 10.1186/1471-2407-11-65.
  • BRUHEIM, KJERSTI; Guren, Marianne; Skovlund, Eva; Hjermstad, Marianne Jensen; Dahl, Olav & Frykholm, Gunilla [Show all 8 contributors for this article] (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 76(4), p. 1005–1011. doi: 10.1016/j.ijrobp.2009.03.010.
  • Bruheim, Kjersti; Tveit, Magne Kjell; Skovlund, Eva; Balteskard, Lise; Carlsen, Erik & Fosså, Sophie Dorothea [Show all 7 contributors for this article] (2010). Sexual function in females after radiotherapy for rectal cancer. Acta Oncologica. ISSN 0284-186X. 49(6), p. 826–832. doi: 10.3109/0284186X.2010.486411.
  • Brændengen, Morten; Tveit, Magne Kjell; BRUHEIM, KJERSTI; Småstuen, Milada C; Berglund, Åke & Glimelius, Bengt (2010). Late patient reported toxicity after preoperative radiotherapy or chemoradiotherapy in non-resectable rectal cancer. Results from a randomized phase III study. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. doi: 10.1016/j.ijrobp.2010.07.007.
  • Bruheim, Kjersti; Guren, Marianne; Dahl, Alv A; Skovlund, Eva; Balteskard, Lise & Carlsen, Erik [Show all 8 contributors for this article] (2010). Sexual function in males after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 76(4), p. 1012–1017. doi: 10.1016/j.ijrobp.2009.03.075.
  • Bruheim, K; Guren, MG; Skovlund, E; Hjermstad, Marianne Jensen; Dahl, O & Frykholm, Gunilla [Show all 8 contributors for this article] (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 76(4), p. 1005–1011. doi: 10.1016/j.ijrobp.2009.03.010.
  • Jetne, Vidar; Kvaløy, Stein Olav; Smeland, Sigbjørn; Johannessen, Tom Børge & Tveit, Magne Kjell (2009). Bruk av stråleterapi i Helse Sør-Øst. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 129(24), p. 2602–2605.
  • Selzer-Plon, Joanna; Bornholdt, Jette; Friis, Stine; Bisgaard, Hanne C.; Lothe, Inger Marie Bowitz & Tveit, Magne Kjell [Show all 9 contributors for this article] (2009). Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer. ISSN 1471-2407. 9. doi: 10.1186/1471-2407-9-201.
  • Skovbjerg, Hanne; Anthonsen, Dorrit; Lothe, Inger M Bowitz; Tveit, Magne Kjell; Kure, Elin H. & Vogel, Lotte K. (2009). Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer. ISSN 1471-2407. 9. doi: 10.1186/1471-2407-9-136.
  • Baatrup, Gunnar; Endreseth, Birger H.; Isaksen, Vidar; Kjellmo, Åse; Kjellmo, Åse & Tveit, Kjell Magne [Show all 7 contributors for this article] (2009). Preoperative staging and treatment options in T1 rectal adenocarcinoma. Acta Oncologica. ISSN 0284-186X. 48(3), p. 328–342. doi: 10.1080/02841860802657243.
  • Tveit, KM; Balteskard, L & Dahl, Olav (2009). Gastrointestinal kreft. In Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg; Kvaløy, Stein & Christoffersen, Thoralf (Ed.), Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. Farmakologisk inst., Fakultetsdivisjonen Rikshospitalet, Det med. fakultet, Universitetet i Oslo, Oslo Universitetssykehus HF - Radiumhospitalet, Seksjon for onkologi, IFI, MOF, Universitetet i Bergen. ISSN 978-82-9923312-5. p. 363–375.
  • Fluge, Øystein; Gravdal, K; Carlsen, E; Carlsen, Erik; Vonen, Barthold & Kjellevold, K [Show all 15 contributors for this article] (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. ISSN 0007-0920. 101(8), p. 1282–1289. doi: 10.1038/sj.bjc.6605333.
  • Dahl, Olav; Fluge, Øystein; Carlsen, Erik; Wiig, Johan N; Myrvold, Helge E & Vonen, Barthold [Show all 11 contributors for this article] (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica. ISSN 0284-186X. 48(3), p. 368–376. doi: 10.1080/02841860902755244.
  • Skjelbred, Camilla Furu; Sæbø, Mona; Li, Karin Brekke; Lothe, Inger Marie Bowitz; Hagen, Per Chr. & Johnsen, Egil [Show all 8 contributors for this article] (2008). CYP1A2 164 A -> C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Anticancer Research. ISSN 0250-7005. 28(4C), p. 2289–2295.
  • Brændengen, Morten; Tveit, Magne Kjell; Berglund, A; Birkemeyer, E; Frykholm, Gunilla & Pahlman, L [Show all 10 contributors for this article] (2008). Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. Journal of Clinical Oncology. ISSN 0732-183X. 26, p. 3687–3694. doi: 10.1200/JCO.2007.15.3858.
  • Glimelius, Bengt; Sørbye, Halfdan; Balteskard, L; Byström, P; Pfeiffer, P & Tveit, KM [Show all 12 contributors for this article] (2008). A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer. Annals of Oncology. ISSN 0923-7534. 19(5), p. 909–914. doi: 10.1093/annonc/mdm588.
  • Qvortrup, C; Yilmaz, M; Øgreid, Dagfinn; Berglund, A; Balteskard, L & Ploen, J. [Show all 11 contributors for this article] (2008). Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil. Annals of Oncology. ISSN 0923-7534. 19, p. 1154–1159. doi: 10.1093/annonc/mdn002.
  • Bruheim, Kjersti; Svartberg, Johan; Carlsen, Erik; Dueland, Svein; Haug, Egil & Skovlund, Eva [Show all 8 contributors for this article] (2008). Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 70(3), p. 722–727. doi: 10.1016/j.ijrobp.2007.10.043.
  • Skjelbred, Camilla Furu; Sæbø, Mona; Hjartaker, Anette; Grotmol, T.; Hansteen, Inger-Lise & Tveit, Kjell Magne [Show all 8 contributors for this article] (2007). Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer. ISSN 1471-2407. 7(228), p. 1–11. doi: 10.1186/1471-2407-7-228.
  • Lorentzen, Anders; Vogel, Lotte K.; Lewinsky, Rikke H.; Sæbø, Mona; Skjelbred, Camilla Furu & Godiksen, Sine [Show all 12 contributors for this article] (2007). Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer. ISSN 1471-2407. 7(192), p. 1–8. doi: 10.1186/1471-2407-7-192.
  • Tveit, Magne Kjell (2005). Svulster i tynntarm, tykktarm, endetarm og anus. In Kåresen, Rolf & Wist, Erik (Ed.), Kreftsykdommer - en basisbok for helsepersonell. Gyldendal Akademisk. ISSN 82-05-33494-3. p. 187–189.
  • Guren, Tormod Kyrre; Christoffersen, Thoralf; Thoresen, G. Hege; Wisløff, Finn Georg B; Tveit, Magne Kjell & Dajani, Olav (2005). Antitumormidler rettet mot tyrosinkinaser. Tidsskrift for Den norske legeforening. ISSN 0029-2001. p. 3115–3119.
  • Glimelius, Bengt; Dahl, Olav; Cedermark, Björn; Jakobsen, Anders; Benzen, Søren M. & Starkhammar, Hans [Show all 11 contributors for this article] (2005). Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica. ISSN 0284-186X. 44(8), p. 904–912. doi: 10.1080/02841860500355900.
  • Glimelius, B; Dahl, O; Cedermark, B; Jakobsen, A; Bentzen, SM & Starkhammar, H [Show all 11 contributors for this article] (2005). Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica. ISSN 0284-186X. 44(8), p. 904–912.
  • Pfeiffer, P; Sorbye, H; Ehrsson, H; Fokstuen, T; Mortensen, JP & Baltesgard, L [Show all 12 contributors for this article] (2005). Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil. Annals of Oncology. ISSN 0923-7534. 17(2), p. 252–258.
  • Guren, MG; Eriksen, MT; Wiig, JN; Carlsen, E; Nesbakken, Arild & Sigurdsson, HK [Show all 8 contributors for this article] (2005). Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. European Journal of Surgical Oncology. ISSN 0748-7983. 31(7), p. 735–742.
  • Tveit, Magne Kjell & Kataja, VV (2005). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer. Annals of Oncology. ISSN 0923-7534. 16, p. 20–21.
  • Guren, Marianne Grønlie; Eriksen, Morten Tandberg; Wiig, Johan N.; Carlsen, Erik; Nesbakken, Arild & Sigurdsson, Helgi Kjartan [Show all 8 contributors for this article] (2005). Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. European Journal of Surgical Oncology. ISSN 0748-7983. doi: 10.1016/j.ejso.2005.05.004.
  • Guren, Marianne Grønlie; Schneede, Jørn; Tveit, Kjell Magne; Ueland, Per Magne; Nexø, Ebba & Dueland, Svein (2004). Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 60, p. 807–813.
  • Sørbye, Halfdan; Glimelius, Bengt; Berglund, Å; Fokstuen, T; Tveit, Kjell Magne & Brændengen, M [Show all 8 contributors for this article] (2004). Multicentre phase II study of Nordic 5-fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology. ISSN 0732-183X. 22.
  • Guren, Marianne G; Dueland, Svein; Skovlund, Eva; Fosså, Sophie Dorothea; Poulsen, J. P. & Tveit, Kjell Magne (2003). Quality of life during radiotherapy for rectal cancer. European Journal of Cancer. ISSN 0959-8049. 39(5), p. 587–594.
  • Dueland, Svein; Guren, Marianne Grønlie; Olsen, Dag Rune; Poulsen, Jan Peter & Tveit, Kjell Magne (2003). Radiation therapy induced changes in male sex hormone levels in rectal cancer patients. Radiotherapy and Oncology. ISSN 0167-8140. doi: 10.1016/s0167-8140%2803%2900120-8..
  • Wiig, J. N.; Tveit, Magne Kjell; Poulsen, J. P.; Olsen, Dag Rune & Giercksky, Karl-Erik (2002). Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiotherapy and Oncology. ISSN 0167-8140. 62(2), p. 207–213.
  • Wiig, J. N.; Tveit, Magne Kjell; Poulsen, J. P.; Olsen, Dag Rune & Giercksky, Karl-Erik (2002). Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT)be of additional benefit? A prospective study. Radiotherapy and Oncology. ISSN 0167-8140. 62(2), p. 207–213.
  • Kringen, Pedro; Egedal, Sidsel; Pedersen, Jan Christian; Harbitz, Thorstein B.; Tveit, Kjell Magne & Berg, Kåre [Show all 8 contributors for this article] (2002). BRCA1 mutation screening using restriction endonuclase fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system. Electrophoresis. ISSN 0173-0835. 23(24), p. 4085–4091.
  • Tveit, Kjell Magne & Christoffersen, Thoralf (2001). Neoplasmer. In Vennerød, Anne Marie (Eds.), Norsk legemiddelhåndbok. Norsk legemiddelhåndbok i/s. p. 91–110.
  • Christoffersen, Thoralf & Tveit, Kjell Magne (2001). Legemidler i neoplasmebehandlingen. In Vennerød, Anne Marie (Eds.), Norsk legemiddelhåndbok. Norsk legemiddelhåndbok i/s. p. 663–696.
  • Guren, Marianne G; Wiig, J. N.; Dueland, Svein; Tveit, Magne Kjell; Fosså, Sophie Dorothea & Wæhre, Håkon. [Show all 7 contributors for this article] (2001). Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. European Journal of Surgical Oncology. ISSN 0748-7983. 27(7), p. 645–651.
  • Guren, Marianne G; Wiig, J. N.; Dueland, Svein; Tveit, Magne Kjell; Fosså, Sophie Dorothea & Wæhre, Håkon. [Show all 7 contributors for this article] (2001). Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. European Journal of Surgical Oncology. ISSN 0748-7983. 27, p. 645–651.
  • Tveit, KM; Dahl, Olav & Kvaløy, Stein O (1999). Behandling med cytostatica. In Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein O & Baksaas, Ingebjørg (Ed.), Cytostatika. Medikamentell kreftbehandling [6. utg.]. Institutt for farmakoterapi , UiO/Den Norske Kreftforening. p. 33–40.
  • Tveit, KM; Giercksky, K-E & Dahl, Olav (1999). Gastrointestinal kreft. In Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein O & Baksaas, Ingebjørg (Ed.), Cytostatika. Medikamentell kreftbehandling [6. utg.]. Institutt for farmakoterapi , UiO/Den Norske Kreftforening. p. 310–317.
  • Tveit, Kjell Magne; Bergan, A.; Dahl, Olav; Giercksky, K-E; Myrvold, H & Norum, J [Show all 8 contributors for this article] (1999). Kolorektalcancer og analcancer. In [Mangler etternavn], [Mangler fornavn] (Eds.), Kolorektalcancer og analcancer En veiledning for leger. Norsk Gastrointestinal Cancer Gruppe /Den Norske Kreftforening. p. 1–67.
  • Christoffersen, Thoralf & Tveit, Magne Kjell (1998). Neoplasmer. In Vennerød, Anne Marie (Eds.), Norsk legemiddelhåndbok. ISSN 82-90732-06-6. p. 151–197.
  • Helle, S.I.; Geisler, J.; Poulsen, J. P.; Hestad, Kjetil; Meadows, K. & Collins, W. [Show all 10 contributors for this article] (1998). Microencapsulated Octreotide in Advanced Gastrointestinal and Pancreatic Cancer: a Phase I Study. British Journal of Cancer. ISSN 0007-0920. 78(1), p. 14–20.
  • Andersen, T.E.; Eiken, Hans Geir; Couch, F. J; Kaada, G.; Skrede, Martina & Johnsen, Hege Britt [Show all 13 contributors for this article] (1998). Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Human Mutation. ISSN 1059-7794. 11, p. 166–174.
  • Suo, Zhenha; Emilens, E.; Tveit, Magne Kjell & Nesland, Jahn M (1998). Expression of the type 1 protein tyrosine kinases in benign and malignant breast leasions. Histopathology. ISSN 0309-0167. 33, p. 514–521.
  • Geisler, Jürgen; Geisler, Stephanie; Lønning, Per Eystein; Småland, Rune; Tveit, Kjell Magne & Refsum, Helga [Show all 7 contributors for this article] (1998). Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients. Clinical Cancer Research. ISSN 1078-0432. 4, p. 2125–2128.
  • Andersen, Tone Ikdahl; Wooster, R.; Laake, Kirsten; Collins, N.; Warren, W. & Skrede, Martina [Show all 14 contributors for this article] (1997). Screening for ESR mutations in breast and ovarian cancer patients. Human Mutation. ISSN 1059-7794. 9, p. 531–536.
  • Tveit, Magne Kjell; Wiig, J. N.; Olsen, Dag Rune; Storaas, A.; Poulsen, J. P. & Giercksky, Karl-Erik (1997). Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiotherapy and Oncology. ISSN 0167-8140. 44, p. 277–282.

View all works in Cristin

View all works in Cristin

  • Hamfjord, Julian; Guren, Tormod Kyrre; Dajani, Olav; Glimelius, Bengt; Sorbye, Halfdan & Pfeiffer, Per [Show all 12 contributors for this article] (2018). Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy. Annals of Oncology. ISSN 0923-7534. 29, p. v109–v109. doi: 10.1093/annonc/mdy149.025.
  • Bryhn, Bente & Tveit, Magne Kjell (2017). Nasjonal tarmkreftscreening skal redusere forekomst og dødelighet av tarmkreft. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 137(21), p. 1664–1664. doi: 10.4045/tidsskr.17.0889.
  • Tarpgaard, Line Schmidt; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, Per; Kure, Elin & Yilmaz, Mette Karen [Show all 11 contributors for this article] (2012). Plasma concentrations of YKL-40 in chemo-naive patients with metastatic colorectal cancer treated with FLOX with or without cetuximab: Results from the NORDIC VII study. Journal of Clinical Oncology. ISSN 0732-183X. 30(15).
  • Kure, Elin H.; Hamfjord, Julian; Larsen, Astrid Marie; Tveit, Magne Kjell & Ikdahl, Tone (2012). KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem. Expert Review of Molecular Diagnostics. ISSN 1473-7159. 12(4), p. 327–328. doi: 10.1586/ERM.12.29.
  • Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, P; Sørbye, Halfdan & Pyrhönen, S [Show all 10 contributors for this article] (2010). Randomized phase III study of 5-fluorouracil/folinate/oxaliplatin given continuously or intermittently with or without cetuximab, as first-line treatment of metastatic colorectal cancer: the Nordic VII study (NCT00145314), by the Nordic colorectal cancer biomodulation group. Annals of Oncology. ISSN 0923-7534. 21, p. 9–9.
  • Bjørnbeth, Bjørn Atle; Labori, Knut Jørgen; Buanes, Trond; Tveit, Magne Kjell; Nordeng, Hans Jørgen & Drolsum, Anders [Show all 7 contributors for this article] (2005). Onkologisk-kirurgisk poliklinikk.
  • Glimelius, Bengt; Sørbye, Halfdan; Balteskard, L; Byström, P; Pfeiffer, P & Tveit, KM [Show all 11 contributors for this article] (2005). A randomised phase III multicenter trial comparing irinotecan in combination with 5FU and folinic acid (FU/FA) given according to the Nordic bolus schedule to irinotecan in combination with 5FU/FA given according to the bolus/infused de Gramont schedule, in patients with metastatic colorectal cancer.
  • Dahl, Olav; Tveit, Kjell Magne; Carlsen, Erik; Wiig, Johan; Myrvold, Helge E. & Gauperaa, Tore [Show all 10 contributors for this article] (2003). Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study.
  • Glimelius, Bengt; Cedermark, B.; Dahl, Olav; Tveit, Kjell Magne; Jakobsen, Anders & Bentzen, S. (2003). Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
  • Sørbye, Halfdan; Glimelius, Bengt; Berglund, Åke; Fokstuen, Tone; Tveit, Kjell Magne & Brændengen, Morten [Show all 8 contributors for this article] (2003). Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancer.
  • Tveit, Magne Kjell (1997). Adjuvant behandling ved operabel tykktarms- og endetarmskreft. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 20:117, p. 2991–2992.
  • Tveit, Magne Kjell (1997). Cytostatica hos primærlegen? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 27:117, p. 3911–3912.
  • Tveit, KM; Bergan, A.; Dahl, Olav; Giercksky, K-E; Myrvold, H & Norum, J [Show all 8 contributors for this article] (1999). Kolorektalcancer og analcancer. En veiledning for leger. Gastrointestinal Cancer Gruppe (NGICG).

View all works in Cristin

Published Apr. 13, 2011 2:54 PM - Last modified June 6, 2016 1:43 PM